Aging isn’t a mystery. It can be understood and overcome.
We are the first and largest company dedicated to the research of longevity and aging in their totality. There are no fragmented solutions to a systemic breakdown.
Each Daughter company is taking a revolutionary approach to tackling one or more of the causes of aging, with a mission of making the solutions affordable and accessible to all.
Learn MoreBOSTON, Jan. 15, 2019 /PRNewswire/ — Life Biosciences has announced the closing of a Series B financing round of $50 million, according to Tristan Edwards, chief executive officer and co-founder. The Company initially targeted a $25 million round but upsized to meet investor demand. The proceeds of the investment will be used to continue Life Biosciences’ and its Daughter Companies’ … Continued
Read Full ArticleFOR IMMEDIATE RELEASE SENOLYTIC THERAPEUTICS KICKS OFF Q1 2019 WITH HIGH-PROFILE SPEAKING EVENTS FEATURING CO-FOUNDERS MARC RAMIS AND MANUEL SERRANO Barcelona-Based Biotech is a Daughter Company of Life Biosciences Funded and Supported by Pioneer in the Study of Age-Related Decline BOSTON, JANUARY 9 — Senolytic Therapeutics, an innovator in senescent cell research and one … Continued
Read Full ArticleMELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 28 December 2018: Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) (“Prana” or “the Company”) has today announced that it has entered into a securities purchase agreement for a lead investment by Boston based Life Biosciences LLC (“Life Biosciences”) to raise up to approximately A$44.5 million (approx. US$31.4 million). … Continued
Read Full ArticleFOR IMMEDIATE RELEASE LIFE LUA SUBSIDIARY OF LIFE BIOSCIENCES NAMED FIERCE BIOTECH INNOVATION AWARD WINNER BOSTON, DECEMBER 13 –Rebecca Willumson, publisher of Fierce Biotech, announced today that Life Lua Technologies Inc., a subsidiary of Life Biosciences Inc., has been named the recipient of the Fierce Innovation Award, Life Sciences Edition, in the Digital Health … Continued
Read Full Article
